Literature DB >> 30166766

Ethical considerations about changing parental attitude towards end-of-life care in twins with lethal disease.

Mohamad-Hani Temsah1.   

Abstract

Advances in critical care and technology capabilities may lead to new ethical encounters in paediatrics, especially in the paediatric intensive care unit (PICU). As each patient has unique psychosocial and clinical condition interactions, paediatricians and healthcare providers must develop and adopt a suitable approach for ethical decision-making in the PICU. The healthcare provider needs to balance the four ethical domains of autonomy, beneficence, non-maleficence and justice, and apply these principles to clinical decision-making. One chief factor for ethical decision-making is to have a patient-centered and family-oriented management that is respectful of cultural background. Healthcare providers also need to observe professional ethical conduct and the applicable national laws. Applying these ethical guidelines in paediatric care ensures a more holistic approach to care, whether in the paediatric wards or the highly technical environment of the PICU. We describe two situations in which the parents of twins with a confirmed lethal disease changed their attitude towards end-of-life from full support to "do not resuscitate" and palliative care, after experiencing the palliative care of the first twin, rather than the futile effect of cardiopulmonary resuscitation in the other twin.

Entities:  

Keywords:  Do not resuscitate; End-of-life care; Ethics; Lethal disease; Twins; Zellweger syndrome

Year:  2018        PMID: 30166766      PMCID: PMC6113781          DOI: 10.24911/SJP.2018.1.11

Source DB:  PubMed          Journal:  Sudan J Paediatr        ISSN: 0256-4408


  10 in total

Review 1.  The parents' journey: continuing a pregnancy after a diagnosis of Patau's syndrome.

Authors:  Louise Locock; Jane Crawford; Jon Crawford
Journal:  BMJ       Date:  2005-11-19

Review 2.  When parents refuse treatment for their child.

Authors:  Alexander A Kon
Journal:  JONAS Healthc Law Ethics Regul       Date:  2006 Jan-Mar

3.  Factors that impact resuscitation preferences for young people with severe developmental disabilities.

Authors:  Sandra Friedman; Dana Gilmore
Journal:  Intellect Dev Disabil       Date:  2007-04

4.  The best-interests standard as threshold, ideal, and standard of reasonableness.

Authors:  L M Kopelman
Journal:  J Med Philos       Date:  1997-06

5.  The needs of parents with children suffering from lethal epidermolysis bullosa.

Authors:  W Y Yuen; J C Duipmans; M F Jonkman
Journal:  Br J Dermatol       Date:  2012-07-05       Impact factor: 9.302

Review 6.  The decision of do not resuscitate in pediatric practice.

Authors:  Mohammed M Jan
Journal:  Saudi Med J       Date:  2011-02       Impact factor: 1.484

7.  Parent resuscitation preferences for young people with severe developmental disabilities.

Authors:  Sandra L Friedman
Journal:  J Am Med Dir Assoc       Date:  2005-07-27       Impact factor: 4.669

8.  Association between religious and socio-economic background of parents of children with solid tumors and DNR orders.

Authors:  Inbal Hileli; Myriam Weyl Ben Arush; Fahed Hakim; Sergey Postovsky
Journal:  Pediatr Blood Cancer       Date:  2013-08-12       Impact factor: 3.167

Review 9.  Zellweger spectrum disorders: clinical overview and management approach.

Authors:  Femke C C Klouwer; Kevin Berendse; Sacha Ferdinandusse; Ronald J A Wanders; Marc Engelen; Bwee Tien Poll-The
Journal:  Orphanet J Rare Dis       Date:  2015-12-01       Impact factor: 4.123

10.  Deciding together? Best interests and shared decision-making in paediatric intensive care.

Authors:  Giles Birchley
Journal:  Health Care Anal       Date:  2014-09
  10 in total
  1 in total

1.  Causes, timing, and modes of death in a tertiary pediatric intensive care unit: Five years' experience.

Authors:  Ayman Al-Eyadhy; Mohamad-Hani Temsah; Gamal M Hasan; Mohammed Almazyad; Ali A Alhaboob; Majed Alabdulhafid; Fahad Alsohime; Ahmed S Alzahrani; Abdullah M Alammari; Faisal S Abunohaiah; Nawaf F Alfawzan; Suhail S Alghamdi
Journal:  Saudi Med J       Date:  2021-11       Impact factor: 1.422

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.